Your account is not claimed yet. You can sign up with ORCID to claim your account.

Apostolos Papachristos

Years Active: 2020-2023
Publications (10 Years): 6

University of Patras (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Patras

Greece

PHD :: Pharmacy

Publications

Apostolos Papachristos, Jai Patel, Maria Vasileiou, George P Patrinos
Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics. Cancers 15 (12) (2023)
Apostolos Papachristos, Jai Patel, Maria Vasileiou, George P Patrinos
Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics. Cancers 15 (12) (2023)
Apostolos Papachristos, Mark J Ratain
Lurbinectedin-induced thrombocytopenia: the role of body surface area. Cancer chemotherapy and pharmacology 89 (5) (2022)
Eleni Karatza, Apostolos Papachristos, Gregory B Sivolapenko, Daniel Gonzalez
Machine learning-guided covariate selection for time-to-event models developed from a small sample of real-world patients receiving bevacizumab treatment. CPT: pharmacometrics & systems pharmacology 11 (10) (2022)
Apostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, Gregory Sivolapenko
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer. The oncologist 25 (10) (2020)
Apostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, Gregory Sivolapenko
In Reply. The oncologist 25 (12) (2020)

Apostolos Papachristos.css-eqlu8i{font-size:small;padding-left:4px;}